Alnylam Pharmaceuticals
ALNY
#646
Rank
ยฃ24.50 B
Marketcap
ยฃ189.29
Share price
-1.45%
Change (1 day)
63.23%
Change (1 year)
Alnylam Pharmaceuticals Inc. is a biopharmaceutical company focused on the R&D and commercialization of RNA interference (RNAi) therapeutics for genetically defined diseases.

Market capitalization of Alnylam Pharmaceuticals (ALNY)

Market cap: ยฃ24.50 Billion

As of March 2025 Alnylam Pharmaceuticals has a market cap of ยฃ24.50 Billion. This makes Alnylam Pharmaceuticals the world's 646th most valuable company by market cap according to our data. The market capitalization, commonly called market cap, is the total market value of a publicly traded company's outstanding shares and is commonly used to measure how much a company is worth.

Market cap history of Alnylam Pharmaceuticals from 2004 to 2025

End of year Market Cap

Year Marketcap Change
2025ยฃ24.50 B0.19%
2024ยฃ24.45 B29.72%
2023ยฃ18.85 B-21.98%
2022ยฃ24.16 B60.84%
2021ยฃ15.02 B35.63%
2020ยฃ11.07 B12.43%
2019ยฃ9.85 B69.55%
2018ยฃ5.81 B-37.66%
2017ยฃ9.32 B258.04%
2016ยฃ2.60 B-51.83%
2015ยฃ5.40 B12.38%
2014ยฃ4.80 B93.58%
2013ยฃ2.48 B319.24%
2012ยฃ0.59 B164.54%
2011ยฃ0.22 B-17.16%
2010ยฃ0.27 B-40.63%
2009ยฃ0.45 B-34.81%
2008ยฃ0.69 B17.08%
2007ยฃ0.59 B47.44%
2006ยฃ0.40 B170.95%
2005ยฃ0.14 B99.11%
2004ยฃ75.03 M

End of Day market cap according to different sources

On Mar 9th, 2025 the market cap of Alnylam Pharmaceuticals was reported to be:

ยฃ24.50 Billion
by Yahoo Finance info icon info icon
ยฃ24.50 Billion
by CompaniesMarketCap info icon info icon
ยฃ24.50 Billion
by Nasdaq info icon info icon

Market capitalization for similar companies or competitors

Name Marketcap Market cap differencediff. Country
ยฃ1.65 B-93.24%๐Ÿ‡บ๐Ÿ‡ธ USA
ยฃ59.87 B 144.35%๐Ÿ‡บ๐Ÿ‡ธ USA
ยฃ7.73 B-68.42%๐Ÿ‡บ๐Ÿ‡ธ USA
ยฃ0.98 B-95.97%๐Ÿ‡บ๐Ÿ‡ธ USA
ยฃ65.4 M-99.73%๐Ÿ‡บ๐Ÿ‡ธ USA
ยฃ176.69 B 621.09%๐Ÿ‡จ๐Ÿ‡ญ Switzerland
ยฃ114.99 B 369.28%๐Ÿ‡ซ๐Ÿ‡ท France
ยฃ13.75 B-43.89%๐Ÿ‡ฎ๐Ÿ‡ฑ Israel